<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.eurekalert.org/pub_releases/2019-11/jn-tom111519.php"/>
    <meta property="og:site_name" content="EurekAlert!"/>
    <meta property="article:published_time" content="2019-11-19T05:00:00+00:00"/>
    <meta property="og:title" content="Treatment of migraine pain in randomized clinical trial"/>
    <meta property="og:description" content="Adults experiencing a migraine of moderate or severe severity took the drug ubrogepant or placebo and reported if after two hours they were free of pain and of their most bothersome migraine-associated symptom in this randomized clinical trial."/>
  </head>
  <body>
    <article>
      <h1>Treatment of migraine pain in randomized clinical trial</h1>
      <address><time datetime="2019-11-19T05:00:00+00:00">19 Nov 2019, 05:00</time> by <a rel="author">JAMA</a></address>
      <p><b>What The Study Did:</b> Adults experiencing a migraine of moderate or severe severity took the drug ubrogepant or placebo and reported if after two hours they were free of pain and of their most bothersome migraine-associated symptom in this randomized clinical trial.</p>
      <p><b>To access the embargoed study: </b>Visit our For The Media website at this link <a href="https://media.jamanetwork.com/">https:/​/​media.​jamanetwork.​com/​</a></p>
      <p><b>Authors: </b>Richard B. Lipton, M.D., of the Albert Einstein College of Medicine in Bronx, New York, is the corresponding author.</p>
      <p>(doi:10.1001/jama.2019.16711)</p>
      <p><u>Editor's Note:</u> The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.</p>
      <hr/>
      <p><b>Media advisory:</b> The full study is linked to this news release.</p>
      <p><b>Embed this link to provide your readers free access to the full-text article </b>This link will be live at the embargo time <a href="https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2019.16711?guestAccessKey=ebc7732d-e666-466d-ada8-55e70734166b&amp;utm_source=For_The_Media&amp;utm_medium=referral&amp;utm_campaign=ftm_links&amp;utm_content=tfl&amp;utm_term=111919">https:/​/​jamanetwork.​com/​journals/​jama/​fullarticle/​10.​1001/​jama.​2019.​16711?guestAccessKey=​ebc7732d-e666-466d-ada8-55e70734166b&amp;utm_source=​For_The_Media&amp;utm_medium=​referral&amp;utm_campaign=​ftm_links&amp;utm_content=​tfl&amp;utm_term=​111919</a></p>
    </article>
  </body>
</html>